Company Updates

Recce announced the formation of a Clinical Advisory Committee to assist in the Board’s growing clinical considerations under the Therapeutic Goods Administration (TGA) Special Access Scheme (SAS).

Kazia Therapeutics share a video interview with leading cancer researcher at the Hunter Medical Research Institute and The University of Newcastle, Dr Matt Dun.

Cirrus was fortunate to meet and pitch to A-list investors at the recent Technology Investment Showcase in Singapore in May

Varian is a global leader in the field of radiation therapy with around 50% market share.

This week the RBA slashed interest rates to a record low of 1.25%, delivering what many economists expect to be the first of two rate cuts in coming months.

Swing Trading, Multi-Strategy and the High Growth Strategy all posted positive returns at 3.39%, 1.1% and 3.85% respectively.

Geocon reaffirmed its position as Canberra’s premier property developer and most identifiable brand in 2019, releasing and building more than 2000 new apartments to the market, across 10 projects.

Global growth fears began to take hold during May, fuelled by escalating trade tensions between China and the US.

Elixinol s pleased to announce that it has successfully completed an institutional placement to fund its ongoing expansion initiatives, with a particular focus on growing its USA CBD business